General Departmental Management
Schedules
TAFS: 075-0120 /X - General Departmental Management
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1000 | ME | Mandatory Expected - Unob Bal: Brought forward, Oct 1 | $16,974,569 | |
| 1000 | DE | Discretionary Expected - Unob Bal: Brought forward, Oct 1 | $1,545,120 | |
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $85,000,000 | ||
| 1840 | BA: Mand: Spending auth:Antic colls, reimbs, other | $10,056,587 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $113,576,276 | See footnotes below | |
| Footnotes for line 1920: | A2: The funds apportioned are in an amount consistent with what HHS estimates as “necessary”, per the HHS approved spend plan to fulfil its statutory authority to support the Physician-Focused Payment Model Technical Advisory Committee under the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). This apportionment is with the understanding that, for FY 2025, HHS has agreed to forgo any transfer of funds from the Trust Fund on grounds that the transfer is not “necessary” under 42 USC section 1395ee(c)(1)(F)(ii) due to the availability of carryover funds. [Rationale: Footnote specifies the source of funding.] | |||
| 6001 | Category A -- 1st quarter | $92,601,707 | ||
| 6012 | Category B -- Prevention and Public Health Funds | $5,645,395 | ||
| 6013 | Category B -- Physician-Focused Payment Model Technical Advisory Committee | $4,715,000 | ||
| 6015 | Category B -- Inflation Reduction Act Drug Data | $4,000,000 | ||
| 6170 | Apportioned in FY 2026 | $6,614,174 | ||
| 6190 | Total budgetary resources available | $113,576,276 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] A2: The funds apportioned are in an amount consistent with what HHS estimates as “necessary”, per the HHS approved spend plan to fulfil its statutory authority to support the Physician-Focused Payment Model Technical Advisory Committee under the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). This apportionment is with the understanding that, for FY 2025, HHS has agreed to forgo any transfer of funds from the Trust Fund on grounds that the transfer is not “necessary” under 42 USC section 1395ee(c)(1)(F)(ii) due to the availability of carryover funds. [Rationale: Footnote specifies the source of funding.] | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] |
| A2 | The funds apportioned are in an amount consistent with what HHS estimates as “necessary”, per the HHS approved spend plan to fulfil its statutory authority to support the Physician-Focused Payment Model Technical Advisory Committee under the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). This apportionment is with the understanding that, for FY 2025, HHS has agreed to forgo any transfer of funds from the Trust Fund on grounds that the transfer is not “necessary” under 42 USC section 1395ee(c)(1)(F)(ii) due to the availability of carryover funds. [Rationale: Footnote specifies the source of funding.] |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.